Lenalidomide Derivative and PROTAC for Controlling Neosubstrate Degradation
Tatsuya Sawasaki(CellFree Sciences (Japan)), Masaru Tanokura(The University of Tokyo)
Cited by 0
Related Papers
AGIA Tag System Based on a High Affinity Rabbit Monoclonal Antibody against Human Dopamine Receptor D1 for Protein Analysis
|PLoS ONE|2016|67
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
|Nature Communications|2023|58
Characterization of a caspase-3-substrate kinome using an N- and C-terminally tagged protein kinase library produced by a cell-free system
|Cell Death and Disease|2010|48
Pyrrothiogatain acts as an inhibitor of GATA family proteins and inhibits Th2 cell differentiation in vitro
|Scientific Reports|2019|41
The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD
|Journal of Biological Chemistry|2019|34